Click here for top ranked funds in sectoral / thematic - pharma and healthcare mutual funds.
However, Scripbox does not recommend investing in sectoral / thematic - pharma and healthcare mutual funds.
The pharma benchmark index itself has been a material underperformer over an extended time frame.
Contrary to common perception, this category is also characterised by higher volatility.Investing in these funds will require investors to have a unique insight into the specific areas of investment that these funds focus on.In addition the investor will need to have the ability,inclination and expertise to monitor the prospects closely.Investors are therefore better off investing in diversified funds rather than this category.
No single fund can achieve what a plan can. Learn why
Historical NAV
₹ 23.945
NAV (Sep 23)
Fund Returns
Last 1Y
41%
Last 3Y
30%
Last 5Y
NA
Last 10Y
NA
Since Inception
30.2%
6 Month CAGR
30.3%
Scheme Information
Investment Objective
The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly in Healthcare and allied sectors in India. The Scheme does not guarantee or assure any returns.
Disclaimer: Products compared like fixed deposits may provide fixed guaranteed returns. Mutual Funds investments are subject to market risk, read all scheme related documents carefully before investing. Past performance is not an indicator of future returns.
Mirae Asset Investment Managers (India) Private Limited manages assets worth 92,647 crores and was set up on 20 November 2006. It's current offering of mutual fund schemes includes 29 equity,36 debt and 9 hybrid funds.
We use a proprietary system to rate mutual funds and based on that make a recommendation or rate the fund as top ranked.
What Scripbox recommendations mean?
Recommended
Scripbox algorithm recommends 2-4 funds for investment for an investment asset class such as large cap, diversified, liquid etc. When you invest for an objective, the algorithm suggests the appropriate asset class and funds.
Top Ranked
Neutral
Not Recommended
Track Record
We look at consistent and long historical performance for our analysis.
Fund Size
We look at the size of the fund with respect to other funds in the category. Larger funds are preferred.
Sub-asset Class View
We check if the sub-category of the fund is recommended by us.
Fund Performance
Consistency of performance over various tenures is analysed for a relative performance stack.
Track Record
We look at consistent and long historical performance for our analysis.
Fund Size
We look at the size of the fund with respect to other funds in the category. Larger funds are preferred.
Impact of Interest Rates
We check the relative interest rate risk of the sub-category of the fund. Lower the better.
Credit Attractiveness
We check the credit quality of the underlying instruments present in the fund. Higher the better.
Equity Funds
Debt Funds
About Mirae Asset Healthcare Fund (G)
About Mirae Asset Healthcare Fund (G)
Mirae Asset Healthcare Fund (G) is a Sectoral / Thematic - Pharma And Healthcare Equity fund and has delivered an annualised return of 30.2% over a period of 3 years. . The fund is managed by Mirae Asset Investment Managers (India) Private Limited. The fund manager’s name is Vrijesh Kasera
Mirae Asset Healthcare Fund (G) Investment Objective
The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly in Healthcare and allied sectors in India. The Scheme does not guarantee or assure any returns. . However, there is no assurance that the objective of the scheme will be realized.
Mirae Asset Healthcare Fund (G) NAV,AUM,Risk
The Mirae Asset Healthcare Fund (G) fund was launched on Jun 02, 2018. The NAV (Net Asset Value) of this Sectoral / Thematic - Pharma And Healthcare Equity fund as of 2021-09-23 is ₹23.95. The total AUM (Asset Under Management) of the fund as of 24/09/2021 is ₹1900.764. The category risk of the Mirae Asset Healthcare Fund (G) fund is Very High Risk. The fund charges 2.1 % as expense ratio.
Mirae Asset Healthcare Fund (G) Holdings
The fund’s highest allocation is towards Equity and has invested 99.7% in this asset class. The top three holdings of the fund are , sun pharmaceuticals industries ltd , divi's laboratories ltd , dr reddy's laboratories ltd , apollo hospitals enterprise ltd , cipla ltd , torrent pharmaceuticals ltd , ipca laboratories ltd , fortis healthcare ltd , lupin ltd , gland pharma ltd , aurobindo pharma ltd , natco pharma ltd , ajanta pharma ltd , j.b. chemicals & pharmaceuticals ltd , krishna institute of medical sciences ltd , biocon ltd , alkem laboratories ltd , laurus labs ltd , sbi life insurance company limited , clean science and technology ltd , srf ltd , dr. lal pathlabs ltd , vinati organics ltd , max financial services ltd , icici lombard general insurance co ltd , tatva chintan pharma chem ltd , syngene international ltd , triparty repo , abbott india ltd
Mirae Asset Healthcare Fund (G) Sip
The minimum SIP (Systematic Investment Plan) amount for this is ₹1000 and you can increase this in multiples of ₹ 100. In case you want to invest a lump sum, the minimum amount to be invested is ₹ 5000.
Mirae Asset Healthcare Fund (G) Investment volatility and Horizon
This fund is meant for investors with a minimum investment horizon of 5-7 years. Due to the asset class nature, expect volatility in your investments over the short term. The fund is benchmarked to S&P BSE Healthcare TR INR
Mirae Asset Healthcare Fund (G) Review
Mirae Asset Healthcare Fund (G) has a score of 3 on a scale of 5. The fund scores 2 out of 5 based on historical performance.
As compared to the other funds in its category, Mirae Asset Healthcare Fund (G) has a score of 4 out of 5
Scipbox has rated this fund 3 out of 5 based on consistency of performance over various years / tenures.
